EN PL
OPIS PRZYPADKU
Guz szyi w przebiegu zespołu Takayasu
 
Więcej
Ukryj
 
Data nadesłania: 28-11-2016
 
 
Data ostatniej rewizji: 10-01-2017
 
 
Data akceptacji: 26-01-2017
 
 
Data publikacji online: 22-03-2017
 
 
Data publikacji: 28-02-2017
 
 
Reumatologia 2017;55(1):56-60
 
SŁOWA KLUCZOWE
DZIEDZINY
STRESZCZENIE
Takayasu arteritis is a rare, idiopathic inflammatory disease of the aorta and its major branches, usually affecting young women of Asian descent. In the course of the disease stenosis, occlusions as well as dilatations and aneurysms of vessels occur. Because of many possible localizations of pathological changes, the symptoms have a wide range, but the most common are a weak pulse or its absence on the brachial artery and a difference in systolic pressure above 10 mm Hg between the upper extremities. Here we present a case report of a young woman with Takayasu arteritis, who presented a palpable mass in the back of her neck, significantly diminished after treatment with glucocorticoids.
REFERENCJE (17)
1.
Vaideeswar P, Deshpande JR. Pathology of Takayasu arteritis: A brief review. Ann Pediatr Cardiol 2013; 6: 52-58.
 
2.
Cong XL, Dai SM, Feng X, et al. Takayasu’s arteritis: clinical features and outcomes of 125 patients in China. Clin Rheumatol 2010; 49: 1889-1893.
 
3.
Balbir-Gurman A, Braun-Moscovici Y. Takayasu arteritis: diverse aspects of a rare disease. IMAJ 2012; 14: 757-759.
 
4.
Molloy ES, Langford CA, Clark TM, et al. Anti-tumour necrosis factor therapy in patients with refractory Takayasu arteritis: long-term follow-up. Ann Rheum Dis 2008; 67: 1567-1569.
 
5.
Killinger Z, Čierny D, Jackuliak P, et al. Long-term efficacy of infliximab for treating Takayasu arteritis. IMAJ Isr Med Assoc J 2012; 14: 771-773.
 
6.
Quartuccio L, Schiavon F, Zuliani F, et al. Long-term efficacy and improvement of health-related quality of life in patients with Takayasu’s arteritis treated with infliximab. Clin Exp Rheumatol 2012; 30: 922P8.
 
7.
Arend WP, Michel BA, Bloch DA, et al. The American College of Rheumatology 1990 criteria for the classification of Takayasu arteritis. Arthritis Rheum 1990; 33: 1129-1134.
 
8.
Park MC, Lee SW, Park YB, et al. Clinical characteristics and outcomes of Takayasu’s arteritis: analysis of 108 patients using standardized criteria for diagnosis, activity assessment, and angiographic classification. Scand J Rheumatol 2005; 34: 284-292.
 
9.
Miyata T, Sato O, Koyama H, et al. Long-term survival after surgical treatment of patients with Takayasu’s arteritis. Circulation 2003; 108: 1474-1480.
 
10.
Kerr GS, Hallahan CW, Giordano J, et al. Takayasu arteritis. Ann Intern Med 1994; 120: 919-929.
 
11.
Mukhtyar C,Guillevin L, Cid MC, et al. EULAR recommendations for the management of large vessel vasculitis. Ann Rheum Dis 2009; 68: 318-323.
 
12.
Maritati F, Ianuuzella F, Pavia MP, et al. Kidney involvement in medium- and large-vessel vasculitis. J Nephrol 2016; 29: 495-505.
 
13.
de Souza AWS, Machado NP, Pereira VM, et al. Antiplatelet therapy for the prevention of arterial ischemic events in Takayasu arteritis. Circ J 2010; 74: 1236P41.
 
14.
Mavrogeni S, Dimitroulas T, Chatziioannou SN, et al. The role of multimodality imaging in the evaluation of Takayasu arteritis. Semin Arthritis Rheum 2013; 42: 401P12.
 
15.
Asai S, Matsushita H, Komiya S. Ultrasonographic Diagnosis ofa Cervical Mass Caused by a Calcified Thrombus as an Initial Manifestation of Takayasu Arteritis. J Ultrasound Med 2007; 26: 271-274.
 
16.
Shiboski SC, Shiboski CH, Criswell LA, et al. American College of Rheumatology Classification Criteria for Sjögren’s Syndrome: A Data-Driven, Expert Consensus Approach in the Sjögren’s International Collaborative Clinical Alliance Cohort. Arthritis Care Res 2012; 64: 475-487.
 
17.
Vuong PN, Berry C. The Pathology of Vessels. Springer-Verlag, Paris 2002; 262-263.
 
Copyright: © Narodowy Instytut Geriatrii, Reumatologii i Rehabilitacji w Warszawie. This is an Open Access journal, all articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) License (https://creativecommons.org/licenses/by-nc-sa/4.0/), allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material, provided the original work is properly cited and states its license.
eISSN:2084-9834
ISSN:0034-6233
Journals System - logo
Scroll to top